To confirm whether NEAT1 and miR-128-3p expression was differentially expressed between normal brain tissues and glioma tissues, we performed qRT-PCR to assess NEAT1 and miR-128-3p expression in grade I–II glioma tissues (LGG) and grade III–IV glioma tissues (HGG), alongside normal brain tissues (NBT); ten cases were selected randomly for each group. Here, NEAT1 is linked to central nervous system cancer.